Test Price
2,800 AED✅ Home Collection Available
📋 Results in 3–4 weeks
CNTNAP2 Gene Cortical Dysplasia-Focal Epilepsy Syndrome Genetic Test in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
This Next-Generation Sequencing (NGS) test detects pathogenic variants in the CNTNAP2 gene responsible for cortical dysplasia-focal epilepsy syndrome, enabling precise molecular diagnosis and personalised therapeutic planning. The assay is processed under ISO-accredited protocols at DNA Labs UAE, Dubai Healthcare City, with full DHA regulatory oversight.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic post-test consultation for result interpretation.
- Insurance Verification: Direct billing inquiry via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CNTNAP2 gene NGS test provides full gene coverage including deep intronic and copy-number variants, delivering a definitive molecular diagnosis for cortical dysplasia-focal epilepsy syndrome. This assay guides targeted therapeutic strategies and informs genetic counselling for affected families.
| Feature | Our Test (NGS) | Standard Single-Gene Sequencing |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) with full gene coverage | Sanger sequencing (limited to hotspot regions) |
| Diagnostic Sensitivity | 99.9% (including deep intronic & copy-number variants) | ~85–90% |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Price | 2,800 AED | 2,500–3,500 AED (often not comprehensive) |
Physician Insight & Safety Protocols
Ms. Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA ID: 9294403: "Genetic evaluation of CNTNAP2 must be integrated with detailed seizure semiology, EEG patterns, and brain MRI findings. This test provides a molecular anchor for diagnosis but does not replace comprehensive clinical assessment. I strongly recommend pre-test genetic counselling to ensure families understand the implications for treatment and recurrence risk."
Medication Advisory
Do not discontinue or alter any prescribed anti-seizure medication without consulting your treating neurologist. Abrupt changes may precipitate breakthrough seizures or status epilepticus.
Safety Exclusion Criteria & Emergency Red Flags
- Individuals with active severe infection or known bleeding disorder should defer blood collection until cleared by their physician.
- This test is not indicated for asymptomatic individuals without a relevant family history; genetic counselling is mandatory prior to testing for all patients, including minors.
- Emergency: If you experience worsening seizures, loss of consciousness, sudden neurological deficit, or severe allergic reaction after sample collection, seek immediate care at Rashid Hospital Emergency Department or call 998.
Patient FAQ & Clinical Guidance
1. What does the CNTNAP2 gene test diagnose?
This test detects pathogenic mutations in the CNTNAP2 gene that cause cortical dysplasia-focal epilepsy syndrome, providing a definitive molecular diagnosis to guide targeted therapy and family counselling.
2. How is the sample collected and what preparation is needed?
A peripheral blood sample, one drop on an FTA card, or extracted DNA is accepted. A pre-test genetic counselling session to document a detailed pedigree is mandatory before sample collection.
3. Is my genetic data protected under UAE law?
Yes, all genomic information is processed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Strict confidentiality is maintained and no third-party sharing occurs.
4. How long does it take to receive results?
The standard turnaround time is 3–4 weeks from sample receipt at the laboratory. Results are delivered electronically and discussed during a telephonic post-test consultation.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
This testing service operates under the regulatory oversight of the Dubai Health Authority (DHA) and adheres to:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring all patient genetic data is processed with explicit consent and secure encryption.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing digital health records and telemedicine components.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – defining clinical responsibility and patient safety standards throughout the testing pathway.
All laboratory processes are ISO-accredited and subject to DHA inspection. Results are released only to the ordering physician or directly to the patient with verified identity.
Clinical & Logistical Metadata
| Test Name | CNTNAP2 Gene Cortical Dysplasia-Focal Epilepsy Syndrome Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral blood (3–5 mL EDTA), FTA card spot, or extracted DNA (≥1 µg). VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM – 11 PM. |
| Methodology Used | Next-Generation Sequencing (NGS) – full gene coverage including intronic and copy-number variant detection |
| ICD-10-CM Code | Q04.3 (Cortical dysplasia), G40.0 (Focal epilepsy) |
| LOINC Code | 78025-5 (CNTNAP2 gene targeted mutation analysis) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["Pre-test genetic counselling session mandatory", "Detailed pedigree documentation required"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians